Antihypertensive effects of a fixed-dose combination of losartan and hydrochlorothiazide plus amlodipine versus a hydrochlorothiazide and atenolol combination plus amlodipine in subjects with ambulatory systolic hypertension

Trial Profile

Antihypertensive effects of a fixed-dose combination of losartan and hydrochlorothiazide plus amlodipine versus a hydrochlorothiazide and atenolol combination plus amlodipine in subjects with ambulatory systolic hypertension

Completed
Phase of Trial: Phase IV

Latest Information Update: 19 Apr 2017

At a glance

  • Drugs Losartan/hydrochlorothiazide (Primary) ; Amlodipine; Atenolol; Hydrochlorothiazide
  • Indications Hypertension
  • Focus Therapeutic Use
  • Most Recent Events

    • 27 Feb 2009 Additional trial centre Merck reported by ClinicalTrials.gov, last updated 27 Feb 2009.
    • 27 Feb 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 06 Nov 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top